19-7534905-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000601870.1(ENSG00000268614):n.*371+3G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0025 in 160,354 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000601870.1 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PNPLA6 | NM_001166111.2 | c.-43+3G>A | splice_region_variant, intron_variant | NP_001159583.1 | ||||
PNPLA6 | NM_001166113.1 | c.-119+3G>A | splice_region_variant, intron_variant | NP_001159585.1 | ||||
PNPLA6 | NM_006702.5 | c.-43+3G>A | splice_region_variant, intron_variant | NP_006693.3 | ||||
PNPLA6 | NM_001166112.2 | c.-43+3G>A | splice_region_variant, intron_variant | NP_001159584.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000268614 | ENST00000601870.1 | n.*371+3G>A | splice_region_variant, intron_variant | 4 | ENSP00000471492.1 |
Frequencies
GnomAD3 genomes AF: 0.00254 AC: 386AN: 152122Hom.: 2 Cov.: 32
GnomAD4 exome AF: 0.000616 AC: 5AN: 8114Hom.: 0 Cov.: 0 AF XY: 0.000227 AC XY: 1AN XY: 4410
GnomAD4 genome AF: 0.00260 AC: 396AN: 152240Hom.: 2 Cov.: 32 AF XY: 0.00263 AC XY: 196AN XY: 74432
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 11, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at